Implantate Extends Contracts of All Board Members

Implantate AG, a global medical device company focused on trauma products and biomaterials for the orthopedic market, has extended the existing contracts of their three executive board members for another three years until the end of the financial year 2015.

Advertisement

“We are glad to have accomplished the extension of the executive management contracts. With this successful team, we are able to further implement our focus strategy and concentrate on value creation as well as sustainable and profitable growth,” said Rubino di Girolamo, chairman of the supervisory board.

More Articles on Orthopedic Devices:

Spinal Elements to Donate Allograft Proceeds to Charity

Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc

SkelRegen Forms With Focus on Musculoskeletal Care

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.